MLPA Probemixes for Congenital Disorders & Carrier Testing

Add to Shortlist

Features & Benefits

Gold standard technique for determining DNA copy number variations
Simple and easy test protocol
Identification of up to 60 DNA sequences in a single reaction
Requires only 50 ng of input DNA sample
Broad detection range from whole genome to single exons
Cost-effective testing as suitable with standard laboratory equipments & low assay costs
Free & intuitive software for data analysis

Product Details

SALSA® MLPA® Probemixes for Congenital Disorders & Carrier Testing are used for determining DNA copy number variations in inherited disorders such as Alpha-Thalassemia (P140 HBA) , Congenital Adrenal Hypoplasia (P050 CAH), Cystic Fibrosis (P091 CFTR), Duchenne Muscular Dystrophy (P034 DMD-1; P035 DMD-2) and Spinal Muscular Atrophy (P021 SMA; P060 SMA Carrier; P460 SMA (Silent) Carrier). MLPA Assay is a simple, robust and multiplex PCR-based assay. It is a semi-quantitative assay targetting the crucial regions, genes and/or exons linked with the mentioned disorders. With PCR amplicons being fluorescently labelled and quantified using capillary electrophoresis, this technology offers an invaluable tool for both diagnostic and research applications. Pack sizes of 25, 50 and 100 reactions.